Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Transcranial low-level laser therapy improves brain mitochondrial function and cognitive impairment in D-galactose-induced aging mice

However, same wavelengths at the fluency of 4 J/cm2 had poor effect on the behavioral and molecular indexes in aging model.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

In a study of D-galactose-treated aging mice, the authors report that transcranial laser therapy at 660 and 810 nm and 8 J/cm2 was associated with better spatial and episodic-like memory and improved brain mitochondrial and apoptosis markers. The lower fluence of 4 J/cm2 had little effect. These are animal results, and the abstract does not report human outcomes.

Who or what was studied
Mice in a D-galactose-induced aging model
Wavelengths
660, 810 nm
Limits stated in the abstract
The study is in mice, and the abstract does not report human outcomes or a participant count.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.

Record from PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
810 nm
Energy density (fluence)
8 J/cm2, 4 J/cm2

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Low-level laser therapy, Laser, Near-infrared, Mitochondria, Reactive oxygen species, Adenosine triphosphate, Cytochrome c oxidase. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Brain & Neurology

Chronic 40-hz light-emitting diode (LED) therapy attenuates cognitive and behavioral deficits and modulates BDNF and caspase-3 expression in a D-galactose/aluminum chloride-induced sporadic Alzheimer's-like rat model

These data suggest that 40-Hz LED stimulation confers neuroprotection in the D-gal/AlCl3-induced AD model, potentially through enhancement of neurotropic signaling and inhibition of apoptosis, supporting its promise as a non-invasive strategy against neurodegenerative decline.

Study · August 7, 2026 · Ghorbani E et al.